![David Campbell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Campbell
Fondatore presso
JANUX THERAPEUTICS, INC.
Patrimonio netto: 5 M $ in data 30/09/2026
Profilo
David Campbell is the founder of Janux Therapeutics, Inc., founded in 2017, where the title held is President, Chief Executive Officer & Director.
Dr. Campbell is also the founder of Thyritope Biosciences, Inc.,Adrenergics, Inc...
Former jobs include President & Chief Executive Officer at Enlibrium, Inc. from 2015 to 2017; Director-Discovery Chemistry at Bayer Corp.; Director-Discovery Chemistry at Affymax Research Institute; Senior Vice President-Drug Discovery & Development at Phenomix Corp.
from 2003 to 2010; Chief Scientific Officer at Afraxis, Inc.; Senior Vice President-Chemical Sciences at ActivX Biosciences, Inc. in 2003; Chief Scientific Officer at Sitari Pharma, Inc. from 2013 to 2019; and Chief Scientific Officer at Iron Horse Therapeutics, Inc. from 2015 to 2019.
Education includes undergraduate studies at Harvey Mudd College and graduate and doctorate degrees from Cornell University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/07/2026 | 264.742 ( 0,44% ) | 5 M $ | 30/09/2026 |
Posizioni attive di David Campbell
| Società | Posizione | Inizio |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Fondatore | 01/06/2017 |
Precedenti posizioni note di David Campbell
| Società | Posizione | Fine |
|---|---|---|
Sitari Pharma, Inc.
 Sitari Pharma, Inc. BiotechnologyHealth Technology Provides pharmaceutical research and development services | Direttore Tecnico/Scientifico/R&S | 01/08/2019 |
Iron Horse Therapeutics, Inc.
 Iron Horse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develop drugs for amyotrophic lateral sclerosis | Direttore Tecnico/Scientifico/R&S | 01/06/2019 |
Enlibrium, Inc.
 Enlibrium, Inc. Medical/Nursing ServicesHealth Services Provides medical services | Amministratore Delegato | 01/12/2017 |
Phenomix Corp.
 Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs | Corporate Officer/Principal | 28/10/2010 |
ActivX Biosciences, Inc.
 ActivX Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drug molecule for hematology, oncology, metabolic and inflammatory diseases | Corporate Officer/Principal | 01/05/2003 |
Formazione di David Campbell
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
54
Relazioni di 1° grado
13
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 13 |
|---|---|
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, healthcare & agricultural products | Health Technology |
Phenomix Corp.
Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs | Health Technology |
Afraxis, Inc.
 Afraxis, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of fragile X syndrome and autism | Health Technology |
Affymax Research Institute
 Affymax Research Institute Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
ActivX Biosciences, Inc.
ActivX Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drug molecule for hematology, oncology, metabolic and inflammatory diseases | Health Technology |
Harvey Mudd College
 Harvey Mudd College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sitari Pharma, Inc.
Sitari Pharma, Inc. BiotechnologyHealth Technology Provides pharmaceutical research and development services | Health Technology |
Thyritope Biosciences, Inc.
 Thyritope Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics that target thyroid stimulating auto-antibodies | Health Technology |
Adrenergics, Inc.
 Adrenergics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics to treat dilated cardiomyopathy | Health Technology |
Enlibrium, Inc.
Enlibrium, Inc. Medical/Nursing ServicesHealth Services Provides medical services | Health Services |
Iron Horse Therapeutics, Inc.
Iron Horse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develop drugs for amyotrophic lateral sclerosis | Health Technology |
Janux Therapeutics, Inc.
 Janux Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops precision engineered immunotherapies | Health Technology |
